Category: Patient-derived mutations impact pathogenicity of SARS-CoV-2
Coronavirus COVID-19 has mutated into 33 different strains, per new study by Professor Li Lanjuan and colleagues from Zhejiang University in Hangzhou, China
A new study paper on Cornavirus (COVID-19) has been published on the medrXiv preprint journal, titled: “Patient-derived mutations impact pathogenicity of SARS-CoV-2”. The research was done at the Zhejiang University in Hangzhou, China. The researchers involved in the study were: Hangping Yao, Xiangyun Lu, Qiong Chen, Kaijin Xu, Yu Chen, Linfang Cheng, Fumin Liu, Zhigang Wu, Haibo Wu, Changzhong Jin, Min Zheng, Nanping Wu, Chao Jiang, Lanjuan Li
Click on this link to visit the medrXiv preprint journal’s website post about this article titled: “Patient-derived mutations impact pathogenicity of SARS-CoV-2”.
From the study: “In total, 33 mutations were identified (including 10 mutations observed in
120 mixed-populations), and 19 of these mutations were novel, according to the comparison
121 with 1111 genomic sequences available at GISAID on 3/24/2020.”
Since there are many mutations, creating a COVID-19 Vaccine will be that much more difficult. I suspect that there are many more mutations, say in Europe. As such, I am of the opinion that a viable Vaccine will not be developed.
One can Download a PDF of the research study paper on the website via the above mentioned link to the medrXiv website.
Click on this link to The Jerusalem Post website to read their article titled: “Coronavirus has mutated into at least 30 different strains new study finds”.
Posted by Vincent Banial